Your browser doesn't support javascript.
loading
Identification of HLA-E Binding Mycobacterium tuberculosis-Derived Epitopes through Improved Prediction Models.
Ruibal, Paula; Franken, Kees L M C; van Meijgaarden, Krista E; van Wolfswinkel, Marjolein; Derksen, Ian; Scheeren, Ferenc A; Janssen, George M C; van Veelen, Peter A; Sarfas, Charlotte; White, Andrew D; Sharpe, Sally A; Palmieri, Fabrizio; Petrone, Linda; Goletti, Delia; Abeel, Thomas; Ottenhoff, Tom H M; Joosten, Simone A.
Afiliación
  • Ruibal P; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Franken KLMC; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • van Meijgaarden KE; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • van Wolfswinkel M; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Derksen I; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Scheeren FA; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Janssen GMC; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
  • van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
  • Sarfas C; Research and Development Department, UK Health Security Agency, Salisbury, United Kingdom.
  • White AD; Research and Development Department, UK Health Security Agency, Salisbury, United Kingdom.
  • Sharpe SA; Research and Development Department, UK Health Security Agency, Salisbury, United Kingdom.
  • Palmieri F; National Institute for Infectious Diseases Lazzaro Spallanzani Scientific Institute for Research, Hospitalization and Healthcare, Rome, Italy.
  • Petrone L; National Institute for Infectious Diseases Lazzaro Spallanzani Scientific Institute for Research, Hospitalization and Healthcare, Rome, Italy.
  • Goletti D; National Institute for Infectious Diseases Lazzaro Spallanzani Scientific Institute for Research, Hospitalization and Healthcare, Rome, Italy.
  • Abeel T; Delft Bioinformatics Lab, Delft University of Technology, Delft, the Netherlands; and.
  • Ottenhoff THM; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Joosten SA; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
J Immunol ; 209(8): 1555-1565, 2022 10 15.
Article en En | MEDLINE | ID: mdl-36096642
ABSTRACT
Tuberculosis (TB) remains one of the deadliest infectious diseases worldwide, posing great social and economic burden to affected countries. Novel vaccine approaches are needed to increase protective immunity against the causative agent Mycobacterium tuberculosis (Mtb) and to reduce the development of active TB disease in latently infected individuals. Donor-unrestricted T cell responses represent such novel potential vaccine targets. HLA-E-restricted T cell responses have been shown to play an important role in protection against TB and other infections, and recent studies have demonstrated that these cells can be primed in vitro. However, the identification of novel pathogen-derived HLA-E binding peptides presented by infected target cells has been limited by the lack of accurate prediction algorithms for HLA-E binding. In this study, we developed an improved HLA-E binding peptide prediction algorithm and implemented it to identify (to our knowledge) novel Mtb-derived peptides with capacity to induce CD8+ T cell activation and that were recognized by specific HLA-E-restricted T cells in Mycobacterium-exposed humans. Altogether, we present a novel algorithm for the identification of pathogen- or self-derived HLA-E-presented peptides.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos